New way to deliver chemo for belly cancer shows promise in early trial

NCT ID NCT06269978

First seen Dec 18, 2025 · Last updated May 15, 2026 · Updated 17 times

Summary

This early-phase study is testing whether giving two standard chemotherapy drugs (5FU and oxaliplatin) directly into the abdomen is safe and effective for people with colorectal cancer that has spread only to the belly lining. About 24 adults with this condition will receive the drugs through a port in the abdomen. The goal is to find the best dose and see how the body handles it, with the hope of controlling the cancer more directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IV COLORECTAL CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-••••

    Contact

  • UT Southwestern/Simmons Cancer Center

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.